Recent development of pH‐responsive theranostic nanoplatforms for magnetic resonance imaging‐guided cancer therapy

X Li, R Yue, G Guan, C Zhang, Y Zhou, G Song - Exploration, 2023 - Wiley Online Library
The acidic characteristic of the tumor site is one of the most well‐known features and
provides a series of opportunities for cancer‐specific theranostic strategies. In this regard …

Novel drug delivery systems for loading of natural plant extracts and their biomedical applications

HS Rahman, HH Othman, NI Hammadi… - International journal …, 2020 - Taylor & Francis
Many types of research have distinctly addressed the efficacy of natural plant metabolites
used for human consumption both in cell culture and preclinical animal model systems …

Inorganic porous nanoparticles for drug delivery in antitumoral therapy

J Parra‐Nieto, MAG Del Cid, IA de Cárcer… - Biotechnology …, 2021 - Wiley Online Library
The use of nanoparticles in oncology to deliver chemotherapeutic agents has received
considerable attention in the last decades due to their tendency to be passively accumulated …

Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents

L Cabeza, G Perazzoli, C Mesas, C Jiménez-Luna… - AAPS …, 2020 - Springer
Colorectal cancer (CRC) is the third most common cancer worldwide. Its poor response to
current treatment options in advanced stages and the need for efficient diagnosis in early …

The emergence of nanoporous materials in lung cancer therapy

D Radhakrishnan, S Mohanan, G Choi… - … and technology of …, 2022 - Taylor & Francis
Lung cancer is one of the most common cancers, affecting more than 2.1 million people
across the globe every year. A very high occurrence and mortality rate of lung cancer have …

Inorganic hybrid nanoparticles in cancer theranostics: Understanding their combinations for better clinical translation

A Shetty, S Chandra - Materials Today Chemistry, 2020 - Elsevier
Drug resistance, tumor heterogeneity, and poor selectivity make cancer treatment with
current modalities a challenging and complicated task. Careful planning of diagnosis and …

Current advances in drug delivery of nanoparticles for respiratory disease treatment

BRC de Menezes, KF Rodrigues… - Journal of Materials …, 2021 - pubs.rsc.org
Cases of respiratory diseases have been increasing around the world, affecting the health
and quality of life of millions of people every year. Chronic respiratory diseases (CRDs) and …

In vivo MRI of hyperpolarized silicon‐29 nanoparticles

G Kwiatkowski, G von Witte, A Däpp… - Magnetic …, 2024 - Wiley Online Library
Purpose The objective of the present work was to test the feasibility of in vivo imaging of
hyperpolarized 50‐nm silicon‐29 (29Si) nanoparticles. Methods Commercially available …

Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer

H Wen, P Poutiainen, E Batnasan, L Latonen, VP Lehto… - Pharmaceutics, 2023 - mdpi.com
Mesoporous silicon nanoparticles (PSi NPs) are promising platforms of nanomedicine
because of their good compatibility, high payload capacities of anticancer drugs, and easy …

Site-Specific 111In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model

D Lumen, S Näkki, S Imlimthan, E Lambidis… - Pharmaceutics, 2019 - mdpi.com
Polyethylene glycol (PEG) has been successfully used for improving circulation time of
several nanomaterials but prolonging the circulation of porous silicon nanoparticles (PSi …